These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10960274)

  • 1. Mesalamine and relapse prevention in Crohn's disease.
    Cottone M; Cammà C
    Gastroenterology; 2000 Aug; 119(2):597. PubMed ID: 10960274
    [No Abstract]   [Full Text] [Related]  

  • 2. Mesalamine for prophylaxis of small bowel Crohn's disease recurrence.
    Bauer WM; Brzezinski A; Lashner BA
    Curr Gastroenterol Rep; 1999 Oct; 1(5):377-83. PubMed ID: 10980975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The suspension of an announced trial on relapse prevention in Crohn's ileitis with a 5-ASA formulation in microgranular form.
    Prantera C; Bellinvia S
    Dig Liver Dis; 2005 Feb; 37(2):135-6. PubMed ID: 15733528
    [No Abstract]   [Full Text] [Related]  

  • 4. 5-aminosalicylates to prevent relapse of Crohn's disease after surgery.
    Doherty G; Moss AC
    Am J Gastroenterol; 2012 Mar; 107(3):487; author reply 487-8. PubMed ID: 22388032
    [No Abstract]   [Full Text] [Related]  

  • 5. Mesalamine in the treatment of active Crohn's disease.
    Dignass A; Marteau P
    Gastroenterology; 2005 Jan; 128(1):245-6; author reply 246. PubMed ID: 15633152
    [No Abstract]   [Full Text] [Related]  

  • 6. Mesalamine maintenance therapy for Crohn's disease.
    Feagan BG; McDonald JW
    Gastroenterology; 2001 Feb; 120(2):585-6. PubMed ID: 11271451
    [No Abstract]   [Full Text] [Related]  

  • 7. Review article: prevention of postsurgical relapse and recurrence in Crohn's disease.
    Cottone M; Orlando A; Viscido A; Calabrese E; Cammà C; Casà A
    Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():38-42. PubMed ID: 12786611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesalamine derivatives in the treatment of Crohn's disease.
    Harrell LE; Hanauer SB
    Gastroenterol Clin North Am; 2004 Jun; 33(2):303-17, ix-x. PubMed ID: 15177540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesalazine as a maintenance treatment in Crohn's disease.
    Sutherland LR; Steinhart AH
    Gut; 1998 Jan; 42(1):143-4. PubMed ID: 9505902
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of 5-aminosalicylates for the maintenance of remission in Crohn's disease.
    Akobeng AK
    Am J Gastroenterol; 2011 Oct; 106(10):1857; author reply 1857-8. PubMed ID: 21979212
    [No Abstract]   [Full Text] [Related]  

  • 11. Debate: should mesalamine be used in Crohn's disease?: comments and conclusions.
    Kamm MA
    Inflamm Bowel Dis; 2005 Jun; 11(6):616-7. PubMed ID: 15905712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-Mercaptopurine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.
    Hayee BH; Harris AW
    Gastroenterology; 2005 Jan; 128(1):249; author reply 249-51. PubMed ID: 15633158
    [No Abstract]   [Full Text] [Related]  

  • 13. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI.
    Lochs H; Mayer M; Fleig WE; Mortensen PB; Bauer P; Genser D; Petritsch W; Raithel M; Hoffmann R; Gross V; Plauth M; Staun M; Nesje LB
    Gastroenterology; 2000 Feb; 118(2):264-73. PubMed ID: 10648454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Improved treatment of Crohn's disease].
    Nau JY
    Rev Med Suisse; 2005 May; 1(18):1241. PubMed ID: 15977716
    [No Abstract]   [Full Text] [Related]  

  • 15. Little benefit from mesalazine taken prophylactically after surgery for Crohn's disease.
    Rutgeerts P
    Gut; 2001 Apr; 48(4):452-3. PubMed ID: 11247886
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of budesonide and mesalamine for active Crohn's disease.
    Lowry PW; Sandborn WJ
    Gastroenterology; 1999 May; 116(5):1263. PubMed ID: 10220523
    [No Abstract]   [Full Text] [Related]  

  • 17. The case against using 5-aminosalicyclates in Crohn's disease: con.
    Stange EF
    Inflamm Bowel Dis; 2005 Jun; 11(6):613-5. PubMed ID: 15905711
    [No Abstract]   [Full Text] [Related]  

  • 18. Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables.
    Cammà C; Giunta M; Rosselli M; Cottone M
    Gastroenterology; 1997 Nov; 113(5):1465-73. PubMed ID: 9352848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesalamine for the prevention of postoperative recurrence: is nearly there the same as being there?
    Sutherland LR
    Gastroenterology; 2000 Feb; 118(2):436-8. PubMed ID: 10648473
    [No Abstract]   [Full Text] [Related]  

  • 20. The case for using 5-aminosalicyclates in Crohn's disease: pro.
    Hanauer SB
    Inflamm Bowel Dis; 2005 Jun; 11(6):609-12. PubMed ID: 15905710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.